Efficacy and Safety of Conventional Symptomatic Drugs Combined with Lencanizumab in the Treatment of Early Alzheimer's Disease: a Multicenter, Prospective, Observational Study

Name: Efficacy and Safety of Conventional Symptomatic Drugs Combined with Lencanizumab in the Treatment of Early Alzheimer's Disease: a Multicenter, Prospective, Observational Study
Published: 2025
License: Public Domain

First Hospital of China Medical University · 2025

ClinicalTrials.gov · Datasets · License: Public Domain · 2025

Open Source ↗

alzheimer-disease alzheimer-s-disease s-disease treatment

alzheimer's disease, mci-ad, early stage alzheimer's disease, alzheimer disease, lencanizumab, treatment, observational

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Efficacy and Safety of Conventional Symptomatic Drugs Combined with Lencanizumab in the Treatment of Early Alzheimer's Disease: a Multicenter, Prospective, Observational Study

Related documents